Personalized surgery trial aims to extend remission for ovarian cancer patients

NCT ID NCT07295132

Summary

This study aims to determine if adding a second major surgery to chemotherapy helps women with recurrent ovarian cancer live longer without their cancer worsening. It focuses on carefully selecting patients whose cancer is responding well to chemotherapy and who are most likely to benefit from the surgery. Participants will be randomly assigned to receive either surgery plus chemotherapy or chemotherapy alone to compare outcomes.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLATINUM-SENSITIVE OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.